Bright Minds Biosciences ... (DRUG)

35.34

-1.90 (-5.10%)

At close: Mar 03, 2025, 3:59 PM

34.92

-1.18%

After-hours: Mar 03, 2025, 04:00 PM EST

Bright Minds Biosciences Cash Flow Statement

Table Mode

Year	FY24	FY23	FY22	FY21	FY20	FY19
Net Income	-2.8M	-7.37M	-14.96M	-8.65M	-480.38K	-78.72K
Depreciation & Amortization	73.36K	72.45K	6.04K	n/a	n/a	n/a
Stock-Based Compensation	839.77K	1.15M	875.06K	880.62K	161.3K	n/a
Other Working Capital	39.81K	-941.72K	771.94K	416.23K	30.68K	36.71K
Other Non-Cash Items	-1.18K	65.1K	-229.57K	144.76K	161.3K	110.12K
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	39.81K	-941.72K	726.31K	306.08K	30.68K	36.71K
Operating Cash Flow	-1.85M	-7.02M	-13.59M	-7.32M	-288.39K	-42.01K
Capital Expenditures	n/a	5.00	n/a	n/a	n/a	n/a
Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	n/a	n/a	n/a	n/a	n/a	n/a
Debt Repayment	-89.73K	-86.11K	-7.16K	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	302.00	1.06M	1.17M	-1.69M	n/a	366K
Financial Cash Flow	810.57K	2.19M	5.2M	26.06M	1.01M	122K
Net Cash Flow	-1.03M	-4.88M	-8.13M	18.96M	719.94K	79.99K
Free Cash Flow	-1.85M	-7.02M	-13.59M	-7.32M	-288.39K	-42.01K